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Abstract 
Cardiotoxicity is a condition where damages caused by toxic chemical exposure are observed in heart and blood 
vessels. Doxorubicin is the most common chemotherapy agents for various types of cancer therapy. However, 
doxorubicin is converted into doxorubicinol known to trigger cardiac disfunctions and release of several cardiac 
biomarkers, such as CK-MB and LDH.  Turmeric is known to be an alternative medical treatment that has the effect 
of neutralizing oxidative stress. This study aimed to evaluate CK-MB and LDH levels in doxorubicin-induced rats 
(20 mg/kgBW) that received turmeric ethanolic extract from curcuma. This was an experimental study conducted 
in February 2020 in the Faculty of Pharmacy Universitas Sumatera Utara. The rats were divided into six group 
and each group consisted of wistar albino male rats. The groups were normal (CMC-Na), positive control (Vitamin 
E 1%+Dox 20 mg/kgBW), negative control (Dox 20 mg/kgBW), treatment I (EEC 100 mg/kgBW+Dox 20 mg/
kgBW), treatment II (EEC 300 mg/kgBW+Dox 20 mg/kgBW), and treatment III (EEC 500 mg/kgBW+Dox 15 mg/
kgBW). Doxorubicin was given 5 mg/kgBW once a week for four weeks. Results showed that the groups that 
received 100 mg/kg BW, 300 mg/kgBW, and 500 mg/kgBW of turmeric ethanol extract demonstrated a reducing 
effect on the biomarkers of cardiac damage, i.e. CK-MB and LDH. Statistically, serum CK-MB and LDH levels at 
dose 500 mg/kgBW showed no significant differences (p>0.05) with the normal and positive treatment group. In 
conclusion, turmeric has a cardioprotective effect.
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Pengaruh Kardioprotektif Ekstrak Etanol Curcuma Longa 
pada Tikus yang Diinduksi Doxorubicin
Abstrak 
Kardiotoksisitas adalah kondisi terjadinya jantung dan pembuluh darah akibat paparan kimia. Doxorubicin diubah 
menjadi doxorubicinol yang diketahui menyebabkan gangguan fungsi jantung dan pelepasan biomarker jantung 
sseperti CK-MB dan LDH. Kunyit dikenal sebagai pengobatan alternatif yang memiliki efek menetralkan stres 
oksidatif. Penelitian ini dilakukan pada Februari 2020 di Fakultas Farmasi Universitas Sumatera Utara. Tujuan 
penelitian ini adalah mengevaluasi kadar CK-MB dan LDH pada tikus yang diberi ekstrak etanol kunyit yang 
diinduksi doksorubisin (20 mg/kgbb). Penelitian dibagi menjadi enam kelompok dan tiap-tiap kelompok terdiri 
atas 4 ekor tikus wistar albino jantan: normal (CMC-Na), kontrol positif (Vitamin E 1%+Dox 20 mg/kgBB), kontrol 
negatif (Dox 20 mg/kgBB), group I (EEC 100 mg/kgBB+Dox 20 mg/kgBB), group II (EEC 300 mg/kgBB+Dox 20 
mg/kgBB), dan group III (EEC 500 mg/kgBB+Dox 15 mg/kgBB). Doxorubicin 5 mg/kgBB diberikan 4 kali. Hasil 
penelitian menunjukkan bahwa kelompok yang diberi ekstrak etanol kunyit dengan dosis 100 mg/kgBB, 300 mg/
kgbb, 500 mg/kgBB memiliki efek penurunan biomarker kerusakan jantung yaitu CK-MB dan LDH. Berdasar atas 
hasil uji statistik kadar CK-MB dan LDH serum pada dosis 500 mg/kgBB tidak terdapat perbedaan yang bermakna 
(p>0,05) dengan kelompok normal dan positif, dapat disimpulkan bahwa kunyit memiliki efek kardioprotektif.
Kata kunci : CK-MB, LDH, kardiotoksisitas 
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Introduction
Doxorubicin (DOX) is used as one of the most 
common chemotherapy agents for various types 
of cancer therapy, which is derived from the 
class of antibiotics anthracyclines.1 In clinical 
use, this class of antibiotics has limitations due 
to side effects, which can cause cardiotoxicity 
that is quite severe in cancer patients, both 
acute and chronic, depending on the dose of 
administration.2
The side effects of doxorubicin are irreversible 
in chronic use, including the formation of 
cardiomyopathy, congestive heart failure, 
nephrotoxic, and hepatotoxic.3,4 As reported by 
Wattanapitayakul,5 the risk of using doxorubicin 
causes side effects in normal tissue, especially 
in the heart, and causes the suppression of the 
immune system. The tissue in the heart organ 
has an active metabolic. Still, this organ has a low 
antioxidant ability compared to other organs 
in the human body. Hence, the heart is very 
vulnerable to damage caused by free radicals, 
one of which is doxorubicin.2 The biological 
picture is shown in general, and the effect of 
using doxorubicin is apoptosis or necrosis.6
In a study conducted by Clafshenkel et al.,7 
administering doxorubicin 4 mg/kg body weight 
in animal mice that is carried out once a week 
for four weeks intraperitoneally (IP) increases 
cardiac fibrosis when compared to a control 
group not administered with doxorubicin. 
Because of doxorubicin’s effects, we need an 
active compound that can protect the heart 
organ (cardioprotective), which cardioprotective 
compounds can provide excellent anti-
inflammatory and antioxidant effects.
In research conducted in vitro, curcumin 
compounds contained in turmeric are cytotoxic, 
where the content of curcumin can inhibit the 
proliferation of cancer cells, and can also reduce 
pain or wound size from cancer. Therefore, 
turmeric is very likely to be used as an anti-
inflammatory and is very useful for anti-cancer 
therapy. The potential of turmeric as a medicinal 
plant can be further investigated so that its 
utilization as traditional medicine can be further 
maximized without adverse side effects.8
Based on the description above, the long-
term cancer therapy with doxorubicin often 
causes multiorgan damage, one of which can 
cause cardiotoxicity. Turmeric plants (Curcuma 
longa Linn = Tumeric) with a content that is rich 
in curcuminoid (curcumin) have properties as 
a potent free radical reducer, thus encouraging 
researchers to test the effectiveness of ethanolic 
extract of Curcuma (EEC) on experimental 
animals induced by doxorubicin in the heart 
organ. The parameters measured are CK-
MB (Creatine kinase-MB) and LDH (Lactate 
dehydrogenase) as biomarkers.
Methods
Microplate Reader, pH meter (OHAUS Starter300 
Portable) Beaker glass (IWAKI CTE33), Multiskan 
Go Reader (Thermo Fisher Scientific 1510), 
analytic measure, Eppendorf tube, vial 1 mL, 
Spatula, Micropipet (1–10 μL, 50-200 μL, 100–
1000 μL) (Eppendorf), Thermometer, automated 
plate washer, Tumeric, Vitamin E, Ketamine 
(Sigma P-4417), Doxorubicin (Merck 109057), 
and CMC-Na (Sigma P-4417) were used in this 
study. Animals used in the research were rats 
(Rattus norvegicus), Wistar males of 150–200 
g (each group consisted of 4 rats). Before the 
study commenced, the animal test was adjusted 
for one week with the room temperature (22–
25°C) under the cycle of 12 hours light/dark, 
with the provision of food and drinking water 
ad libitum. Ethics Commission from health and 
science commission, University Prima Indonesia 
approved this study (No. 012/KEPK/UNPRI/
II/2020). The present study was conducted in 
the Faculty of Pharmacy, Universitas Sumatera 
Utara, and the serum was analyzed at the North 
Sumatera Regional Health Laboratory. 
Air-dried Curcuma Longa (800 g) was 
extracted with 90% ethanol (12 L) three times 
(2h each) using a soxhlet under reflux. The 
ethanol extract was concentrated under vacuum 
to give a crude extract (150 g). Qualitative 
analytical phytochemical screening of the 
ethanol Curcuma extract method consisted of 
identification of phenol, steroids/terpenoids, 
saponins, flavonoids, tannin, and alkaloids.
In vivo, an experiment was conducted by using 
24 Wistar rats (Rattus norvegicus) male and 
weight 150–200 g, divided into six groups, and 
each group consisted of 4 rats. The groups were 
Normal (Suspension Na-CMC), Negative control 
(male Wistar rats [Rattus norvegicus] induced 
by doxorubicin 20 mg/kgBW), Positive control 
(male Wistar rats [Rattus norvegicus] induced 
by doxorubicin 20 mg/kgBW + Vitamin E 1%), 
Group I (male Wistar rats [Rattus norvegicus] 
induced by doxorubicin 20 mg/kgBW + EEC 100 
mg/kgBW), Group II (male Wistar rats [Rattus 
norvegicus] male induced by doxorubicin 20 mg/
kgBW + EEC 300 mg/kgBW), and Group III (male 
Wistar rats [Rattus norvegicus] induced by 
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Table 2 CK-MB Level







Post tukey test p<0.05 #: has a significant different with 
negative group; p>0.05 *: No significant different with 
normal
Table 1 Results of Phytochemical Screening   








Table 3 LDH Level
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doxorubicin 20 mg/kgBW + EEC 500 mg/kgBW)
Rats were induced by doxorubicin with an 
accumulative dose of 20 mg/kgBW for over 
21 days, with a 5 mg/kgBW dose once a week. 
Before treatment, the rats were given the extract 
with a dose of 100 mg/kgBW, 300 mg/kgBW, 
and 500 mg/kgBW for 21 days. On the last day 
of treatment, the rats were not given any food or 
water for 18 hours before undergoing surgery 
for the animal test. Rats were administered with 
ketamine 70 mg/kgBW intraperitoneally, and 
then underwent surgery. Thoracic dissection was 
performed and 3 mL of blood was collected and 
then transferred a microtube to be centrifuged 
for 10 minutes at 3,000-4,000 rpm of speed until 
it was separated into serum, and supernatant. 
Next, 1 mL of serum was collected and put into 
microtubes to be stored in the refrigerator at a 
temperature of 4°C for determination of CK-MB 
and LDH.  Measurement of the CK-MB and LDH 
levels was performed by following the method 
[9]. As much as 50 µl samples and 500 µl of CK-
MB reagent/LDH was mixed in a test tube. The 
initial absorbance was then read after 1 minute 
at a wavelength of 340 nm. Next, the absorbance 
was measured again after 1, 2, and 3 minutes. Test 
analysis was carried out using one-way analysis 
of variance (ANOVA), followed by Post Hoc Test 
using the Tukey HSD test. In this study, P<0.05 
was considered as a statistical significance. Data 
analysis was performed using the IBM SPSS 20.
Results 
The results of phytochemical screening 
qualitatively in Curcuma extract were shown in 
the Table 1. Phytochemical screening of ethanol 
extract of Curcuma showed the positive result 
of flavonoids, tannins, saponins, glycosides, 
alkaloids, and steroids. In this study, an 
examination of CK-MB from the blood of rats 
was carried out. The results of serum CK-MB 
obtained can be seen in Table 2.
Based on Table 2, it is known that the average 
serum CK-MB value for the normal group was 
still within the normal range of 323.63±5.00 U/L.
The negative control group (doxorubicin 
induction) had an average serum CK-MB of 
997.53±7.44 U/L. The positive control group had 
an average serum CK-MB of 442.23±3.19 U/L 
while the treatment group I had a serum CK-MB 
value of 751.73±12.67 U/L. The treatment group 
II had a serum CK-MB value of 427.03±2.46 U/L 
and the treatment group III had a serum value of 
379.32±34.57 U/L.
Based on the table, it was revealed that the 
average serum CK-MB in the most extensive 
treatment group was 751.73±12.67 U/L in 
treatment group I. Furthermore, the ordinary 
serum CK-MB in the smallest treatment group is 
379.32±34.57 U/L in treatment group III, as can 
be seen in Figure 1.
In this study, an examination of LDH in the 
blood of rats was carried out. The results of 
serum LDH obtained can be seen in Table 3. 
Based on the table, it is known that the average 
serum LDH value for the normal group is still 
within the normal range of 551.36±5.29 U/L.








normal group negative group positive group group I group II group III
CK-MB Level
Figure 1 CK-MB Level
Figure 2 LDH
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The positive control group (doxorubicin 
induction) had an average serum LDH of 2153.66 
U/L. Treatment group I had a serum LDH value 
of 1245 U/L. Treatment group II had a serum 
LDH value of 916.33 U/L. Treatment group III 
had a serum value of 839.33 U/L, and a positive 
control group using Vitamin E as a comparison 
had an average serum LDH of 784 U/L.
Based on the Table 3, it is known that the 
average serum LDH in the most extensive 
treatment group is 1245 U/L in treatment group 
I. Furthermore, the ordinary serum LDH in 
the smallest treatment group is 839.33 U/L in 
treatment group III. 
Discussion
Based on statistical test results, serum CK-
MB levels in the normal group had significant 
differences (p<0.05) with the negative control 
treatment group, treatment group I, treatment 
group II, and treatment group II and did not have 
significant differences (p>0.05) with a positive 
control group with vitamin e supplementation. 
Serum levels of CK-MB negative control group 
had significant differences (p<0.05) with the 
negative control treatment group, treatment 
group I, treatment group II, and treatment group 
II, and the positive control group with vitamin e 
supplementation.
Serum levels of CK-MB positive control group 
presented significant differences (p<0.05) with 
the negative control treatment group, the normal 
group, and the treatment group I and insignificant 
difference (p>0.05) with the positive control 
group, treatment group II, and treatment group II. 
Serum levels of CK-MB in treatment group I had a 
significant difference (p <0.05) with the negative 
control group, normal group, positive control 
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group, treatment group I, and treatment group II. 
Serum levels of CK-MB treatment group II, with 
significant differences (p<0.05) with the normal 
group, negative group, and treatment group I, 
without significant difference (p>0.05) with a 
positive control group and treatment group III. 
Serum levels of CK-MB in treatment group III had 
a significant difference (p<0.05) with the normal 
group, negative group, and treatment group I, 
with no significant differences (p>0.05) with a 
positive control group and treatment group II.
Based on statistical test results, serum LDH 
levels in the normal group had a significant 
difference (p<0.05) with the negative control 
treatment group, treatment group I, treatment 
group II, and treatment group II, without 
significant difference (p>0.05) with the group 
positive control with vitamin e supplementation. 
Serum LDH levels in the negative control group 
had significant differences (p<0.05) with the 
negative control treatment group, treatment 
group I, treatment group II, and treatment group 
II, and the positive control group with vitamin e 
supplementation.
Serum LDH levels in the positive control 
group had significant differences (p<0.05) 
with the negative control treatment group, 
the normal group, and the treatment group I, 
without significant difference (p>0.05) with the 
positive control group, treatment group II, and 
the treatment group II. Serum LDH levels in the 
treatment group I had a significant difference 
(p<0.05) with the negative control group, normal 
control group, positive control group, treatment 
group I, and treatment group II. Serum LDH level 
in treatment group II had a significant difference 
(p<0.05) with the normal group, the negative 
group, and the treatment group I, without 
significant difference (p>0.05) with the positive 
control group and treatment group III. Serum LDH 
levels in the treatment group III had a significant 
difference (p<0.05) with the normal group, 
the negative group, and the treatment group I, 
without significant difference (p>0.05) with the 
positive control group and treatment group II. 
Tumeric and saffron extract was used to prevent 
cardiac toxicity caused by doxorubicin. This study 
identified the cardioprotective effect of turmeric 
on doxorubicin-induced cardiotoxicity in mice. 
Curcumin has been used in traditional medicine 
since it has a cardioprotective, hepatoprotective, 
and chemopreventive effect on various cancers. 
Also, it can reduce lipid levels.10 The mechanism 
of cardiotoxicity caused by doxorubicin is 
known from this study. However, a large amount 
of evidence points towards the formation of 
oxygen free radicals, which can damage cells 
by lipid peroxidation.11 Damage to heart tissue 
may be caused by increased oxidative stress and 
the depletion of similar antioxidants in mice 
previously reported.12
Giving turmeric increases antioxidant levels. 
Thus, it prevents heart damage, mainly due to 
the antioxidant action of curcumin. Turmeric 
ethanol extract prevents doxorubicin-induced 
histological changes in rat heart tissue by 
restoring endogenous antioxidant activity or as 
an antioxidant or both.13
In this study, it can be concluded that 
cardiotoxicity caused by doxorubicin is related 
to oxidative stress. Anti-proliferation, anti-
initiation, and scavenging properties of free 
radicals from turmeric can increase myocardial 
integrity and reduce cardiac toxicity.14
Turmeric is proven to be cardioprotective, 
which can be attributed to its strong antioxidant 
properties. This research shows that turmeric 
can be considered a potentially useful candidate 
combined with Dox to limit free radical-mediated 
organ injury.15 
In conclusion, the ethanol extract of Curcuma 
has a cardioprotective effect by reducing the level 
of heart damage biomarkers, namely LDH and CK-
MB. Curcuma was proven to be cardioprotective, 
which can be potentially developed as herbal 
medicine as additional therapy while using 
doxorubicin.
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